The biologic excipients market has become a vital component of the pharmaceutical and biotechnology industries, playing a crucial role in the formulation of biologic drugs. These excipients are inactive substances used alongside active pharmaceutical ingredients (APIs) to ensure stability, bioavailability, and effective delivery of the drug. As the demand for biologics such as monoclonal antibodies, …
Continue reading “Biologic Excipient Market Forecasted to Expand from USD 1.5 Billion in 2024”